Clinical trials
Phase 4 Dermatitis, Atopic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
70 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 7 |
| 2010 | 4 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Terminated | 8 |
| Recruiting | 7 |
| Not yet recruiting | 4 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 7 |
| Sanofi | 5 |
| Astellas Pharma Inc | 4 |
| Wake Forest University Health Sciences | 4 |
| Derm Research, PLLC | 3 |
| Novartis | 3 |
| Wake Forest University | 3 |
| Fougera Pharmaceuticals Inc. | 2 |
| Johns Hopkins University | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatitis, Atopic | 70 |
| Eczema | 17 |
| Pruritus | 6 |
| Dermatitis | 4 |
| Psoriasis | 4 |
| Asthma | 2 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Coinfection | 1 |
| Facies | 1 |
| Folliculitis | 1 |
Trials
Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.